Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes

BACKGROUND: The role of tyrosine kinase inhibitors (TKI) in the neoadjuvant setting and the optimal duration of therapy remains poorly defined. As such, we aim to evaluate the impact of neoadjuvant TKI on oncological and functional outcomes in our cohort of patients with rectal GISTs. METHODS: A ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Zachary Zihui, Wong, Jolene Si Min, Teo, Melissa Ching Ching, Chia, Claramae Shulyn, Ong, Chin-Ann Johnny, Farid, Mohamad, Tan, Grace Hwei Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055628/
https://www.ncbi.nlm.nih.gov/pubmed/33528660
http://dx.doi.org/10.1007/s10147-021-01867-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055628/
https://www.ncbi.nlm.nih.gov/pubmed/33528660
http://dx.doi.org/10.1007/s10147-021-01867-2

Ejemplares similares